share_log

派林生物(000403.SZ):广东双林二期工程预计2025年下半年投产,年产能将提升至1500吨

Pailin Biotech (000403.SZ): Guangdong Shuanglin Phase II Project is expected to be put into operation in the second half of 2025, and the annual production capacity will increase to 1,500 tons

Gelonghui Finance ·  May 9 04:49

Gelonghui, May 9, 丨 Pailin Biotech (000403.SZ) held a performance briefing on May 7, 2024. Regarding “the expected increase in production capacity after the Guangdong Shuanglin production workshop construction project is put into operation,” the company replied that the Guangdong Shuanglin Phase II project is expected to be put into operation in the second half of 2025, and the annual production capacity will increase to 1,500 tons.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment